Business

argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026

February 19, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 26, 2026 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2025 financial results and provide a fourth quarter business update. A webcast of the live call may be accessed on the Investors section of the argenx w

articleArgenx SeFebruary 19, 20261/company/argenx-se/news/argenx-to-report-full-year-2025-financial-results-and-fourth-quarter-business-update-on-february-26-2026-1
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026

About this update from Argenx Se

[{"type":"image","alt":"argenx SE","displaySize":"","headline":null,"caption":"argenx SE","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":97,"url":"https://media.zenfs.com/en/globenewswire.com/f35a3a919b58945aa6a1a93a9b760119"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_55.hEettGltaZ5cA.9xTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f35a3a919b58945aa6a1a93a9b760119","width":300,"height":97}},"lazy":false},{"type":"text","content":"February 19, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 26, 2026 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2025 financial results and provide a fourth quarter business update.","length":422,"tagName":"p"},{"type":"text","content":"A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation.","length":233,"tagName":"p"},{"type":"text","content":"Dial-in numbers:","length":16,"tagName":"p"},{"type":"text","content":"Belgium           32 800 50 201France                    33 800 943355Netherlands           31 20 795 1090United Kingdom 44 800 358 0970United States           1 888 415 4250Japan                    81 3 4578 9081Switzerland           41 43 210 11 32","length":636,"tagName":"p"},{"type":"text","content":"Use the access code 3810049 to join the call. Please dial in 15 minutes prior to the live call.","length":95,"tagName":"p"},{"type":"text","content":"About argenx","length":12,"tagName":"p"},{"type":"text","content":"argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases....

More updates from Argenx Se

autoimmune diseasesargenx